Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02964442Not ApplicableCompleted

Brown Adipose Tissue Activation and Energy Expenditure by Capsinoids Stimulation With Trimodality Imaging Using 18-FDG-PET, Fat Fraction MRI and Infrared Thermography

Role: collaborator

NCT05342012Not ApplicableCompleted

The Effect of Nitrate on Brown Fat

Role: collaborator

NCT04825067Not ApplicableUnknown

Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases

Role: lead

NCT04809571Not ApplicableUnknown

Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring

Role: lead

NCT03281083Phase 2Terminated

Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)

Role: collaborator

All 5 trials loaded